EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Kardex (KARN) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Kardex CHF 107, price CHF 241, upside -55.5%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Industrials · CH · ISIN CH0100837282

K Broad data Sep 24, 2026

Kardex

KARN · SW

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value CHF 107.07 · Strongly overvalued (−55%)
Quality 65/100
Healthy Growth (revenue 5y +15.7 %/yr)
!Thin margins · 4.9% net margin (TTM)
Low debt · generates free cash flow
·2.68% dividend yield
!Mixed vs. peers (7/14)
!Moderate moat 56/100
!Insider activity 45/100
!Weak on future: 16 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

CHF 327.54 CHF 115.47 Fair Value CHF 107.07 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range CHF 115.47 – CHF 327.54 · fair‑value band CHF 80.31 – CHF 133.84 · the CHF 240.50 price screens above the CHF 107.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Kardex in your weekly email

Every Wednesday you see whether Kardex is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kardex Holding AG provides intralogistics solutions in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates through two segments, Automated Products and Standardized Systems.

Show more

Kardex Holding AG provides intralogistics solutions in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates through two segments, Automated Products and Standardized Systems. The company provides intelligent entry into automation with its dynamic storage and retrieval systems; offers integrated material handling systems, multi-shuttle technology, small parts storage systems and automated high-bay warehouses; storage and picking solutions for small parts; bin shuttle systems for lightgoods; storage and order fulfillment solutions; and life cycle services, as well as system upgrades, support, and digital services. It also provides vertical lift, Buffer, and carousel, as well as horizontal carousel modules; heavy-duty units; cubic bin storage solutions; power pick system; power pick cloud; control centers; machine interface software solutions; java machine interface; mobile data entry; plastic bins designed to store and transport goods for various industries; storage of heavy and oversized goods; vertical lift module boxes; stacker cranes; pick and place robotics; solutions for warehouse storage, order picking, packing, and shipping; and conveyor systems, as well as AutoStore solutions. Its products are used in automated storage and retrieval systems, buffering and sequencing, production and distribution logistics, spare parts management, and controlled environment. The company serves various sectors, such as automotive, chemicals, food and beverage, hospitals, mechanical engineering, pharmaceuticals, tyres, wood panel handling, E-commerce and retail, wholesale, third part logistics, public administration, and media storage and retrieval applications. Kardex Holding AG was founded in 1922 and is based in Zurich, Switzerland.

Stock analysis

Kardex (KARN) currently trades at CHF 240.50, while our model-based Fair Value estimate is CHF 107.07, implying the stock looks roughly 124.6% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of CHF 167.98 per share, and 0 of the 26 models we run sit above the CHF 240.50 price.

Bear case: the Asset-Based group reads lowest at CHF 23.28, and 26 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: CHF 80.31 (bear) to CHF 133.84 (bull), the price of CHF 240.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 65/100 (solid quality), in the Industrials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Kardex reported revenue of €855M in FY2025 versus €456M in FY2021, a compound +17.1%/yr. Reported net income was €41.9M in FY2025, compounding −1.2%/yr from FY2021.

Key figures

Market cap CHF 1.9B · P/E ratio 48.4 · P/S ratio 2.37 · EPS (TTM) CHF 4.97 · Dividend yield 2.7% · Net margin 4.9% · Return on equity 15.1% · Return on assets (EBIT) 18.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.

The share trades about 24% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −50% fair-value upside, at −55%, KARN screens richer than that median.

Fair Value models

Bear CHF 80.31 Fair Value CHF 107.07 Bull CHF 133.84
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF CHF 111.90 CHF 167.98 CHF 252.10 80
Growth DCF CHF 112.87 CHF 161.43 CHF 229.34 79
Owner Earnings CHF 96.64 CHF 144.11 CHF 215.31 76
All 26 models by family
DCF Models
FCF DCF CHF 111.90 CHF 167.98 CHF 252.10 80
Owner Earnings CHF 96.64 CHF 144.11 CHF 215.31 76
5Y Revenue Exit CHF 120.97 CHF 191.52 CHF 282.72 72
5Y EBITDA Exit CHF 128.72 CHF 206.28 CHF 297.82 75
5Y P/E Exit CHF 97.13 CHF 146.14 CHF 197.89 71
10Y Revenue Exit CHF 113.05 CHF 176.12 CHF 263.10 66
10Y EBITDA Exit CHF 121.44 CHF 186.23 CHF 274.55 68
10Y P/E Exit CHF 101.61 CHF 145.03 CHF 198.78 64
Earnings-Based
Graham-Dodd CHF 36.91 CHF 124.82 CHF 167.33 64
Lynch FV CHF 28.53 CHF 40.76 CHF 52.99 61
PEG = 1.0 CHF 28.53 CHF 40.76 CHF 52.99 57
EPV CHF 101.85 CHF 115.96 CHF 128.12 74
Dividend Discount
Gordon GGM CHF 55.58 CHF 110.74 CHF 167.69 67
DDM Multi-Stage CHF 55.58 CHF 93.82 CHF 116.89 67
Multiples
P/E Multiple CHF 85.49 CHF 113.98 CHF 142.48 63
P/S Multiple CHF 69.20 CHF 92.27 CHF 115.34 58
P/B Multiple CHF 69.20 CHF 92.27 CHF 115.34 55
EV/EBIT CHF 178.56 CHF 233.90 CHF 289.24 66
EV/EBITDA CHF 152.98 CHF 199.79 CHF 246.61 67
EV/Revenue CHF 131.03 CHF 181.81 CHF 232.60 54
Asset-Based
NCAV (Graham) CHF 17.38 CHF 23.28 CHF 34.75 54
Growth DCF
Growth DCF CHF 112.87 CHF 161.43 CHF 229.34 79
Rev-Margin DCF CHF 120.97 CHF 190.96 CHF 273.09 72
Economic Profit
Residual Income CHF 34.75 CHF 42.65 CHF 78.84 73
ROIC Compounder CHF 107.01 CHF 128.12 CHF 150.58 72
Growth Earnings
Growth-Adj P/E CHF 72.80 CHF 104.00 CHF 135.20 67

Open the full fair value analysis →

Notify me when KARN reaches fair value

Put KARN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 65/100

Of which business quality 66 · Market factors (momentum, volatility) 33

Profitability 69
Margins and returns on capital today
Quality Growth 42
Are margins and returns improving?
Cashflow 45
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 64
Disciplined investing over empire-building
Low Volatility 47
Calm price path (market factor)
Momentum 34
Price trend over the last 3–12 months (market factor)
52W Momentum 15
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+8.1%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.8%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
Start year 2020 (pandemic). Over 10 years: +9.7% a year
Revenue growth 23 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
What shareholders gained per year (last 5 years) What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+13.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.7%
Dividend (yield on the price)2.7%
Pace: 5 vs 10 years Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−1% vs 4%, slowing
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 12%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+27.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect Analysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +24.8% a year for the price and +6.8% for the forecasts.
Forecast 2026 (sales)+4.9%
Forecast 2027 (sales)+12.2%
Projected 2028 (sales)+10.9%
Projected 2029 (sales)+9.6%
Projected 2030 (sales)+8.4%

KARN screens 125% overvalued. Compare with GE Vernova Inc →

Earlier news

News mood News mood, the average tone of recent news (16 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Kardex with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 826 stocks

Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 65 · Top 25%
Fair Value upside −56% · Below median
Profitability
Return on equity (TTM) 15% · Top 25%
Return on assets 13% · Top 25%
Net margin (TTM) 5% · Below median
Operating margin (TTM) 12% · Above median
Growth and dividend
Revenue growth 3% · Below median
Dividend yield (TTM) 2.7% · Top 25%

Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper

P/E (TTM) 48.4× · Pricier than median
P/B 8.40× · Priciest 25%
P/S (TTM) 2.65× · Pricier than median
P/FCF 57.3× · Priciest 25%
EV/EBITDA 14.6× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)16 · sector 22
PAST (return on equity)60 · sector 28
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)54 · sector 25

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
GE Vernova Inc GEV $950.28 $194.25 −80%
SIE SIE €273.85 €150.21 −45%
Eaton Corporation ETN $442.49 $172.75 −61%
Parker-Hannifin Corporation PH $964.85 $418.76 −57%
Cummins Inc CMI $526.13 $359.38 −32%
Illinois Tool Works Inc ITW $270.47 $151.39 −44%
Emerson Electric Co EMR $154.19 $62.15 −60%
AMETEK, Inc AME $245.41 $125.80 −49%
Rockwell Automation, Inc ROK $427.19 $138.24 −68%
Sandvik AB SAND kr 383.50 kr 193.39 −50%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Kardex Fair Value". https://www.fairvalue-calculator.com/stock/KARN

Frequently asked questions

Is Kardex (KARN) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of CHF 107.07 versus a price of CHF 240.50, about −55% upside (overvalued).
What is the fair value of KARN?
Our model-based fair value for Kardex is CHF 107.07 (as of Sep 24, 2026), built from audited fundamentals. The current price: CHF 240.50.
What is the quality score of KARN?
Kardex has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kardex (KARN)?
Our model-based price target is the fair value of CHF 107.07 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario CHF 80.31, optimistic scenario CHF 133.84. It is a calculation from audited fundamentals, not an analyst target.
What is the Kardex stock forecast for 2026?
Our models put fair value at CHF 107.07, about −55% upside versus a price of CHF 240.50 (overvalued). Cautious scenario CHF 80.31, optimistic scenario CHF 133.84. The calculation is refreshed regularly with new filings.
What is the revenue of Kardex (KARN)?
Kardex reported trailing-twelve-month revenue of about €850M (latest available figure, as of Sep 24, 2026).
Does Kardex pay a dividend?
Kardex currently shows a dividend yield of about 2.68% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Kardex (KARN)?
For today's price to be fair in a discounted-cash-flow model, Kardex would have to grow free cash flow by +27.6 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of KARN use?
Our models discount Kardex at 10.4 %: a base by market capitalisation (mid), damped by beta 1.37, country premium for Switzerland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kardex that is +27.6 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has Kardex (KARN) delivered so far?
Over the past 5 years revenue at Kardex grew +15.7 % a year. The price currently implies +27.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kardex (KARN) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Kardex (+27.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kardex (KARN)?
The free-cash-flow yield on the price is 1.99 %: that much free cash flow Kardex produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kardex (KARN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kardex it is CHF 107.07 per share (as of Sep 24, 2026), against a price of CHF 240.50. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Kardex stock overvalued or undervalued in 2026?
As of Sep 24, 2026, KARN trades above its calculated fair value: price CHF 240.50, fair value CHF 107.07, a gap of about −55% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KARN?
No. The price is what the market pays today (CHF 240.50); the fair value is what the company's own numbers justify (CHF 107.07). For Kardex the two are CHF 133.43 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kardex worth?
The market values Kardex at about CHF 1.9B (market capitalisation, as of Sep 24, 2026). Per share that is CHF 240.50; our models calculate a fair value of CHF 107.07 per share.
What do the bullish and bearish scenarios say about KARN?
Our models span a range for Kardex: cautious scenario CHF 80.31, base CHF 107.07, optimistic CHF 133.84 per share (as of Sep 24, 2026, price CHF 240.50). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of KARN?
Kardex trades at a price-to-earnings ratio of 48.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of CHF 107.07 is built from several models across several years. Other multiples: P/B 8.4, P/S 2.6, EV/EBITDA 14.6.
How solid is the balance sheet of Kardex (KARN)?
Balance-sheet figures for Kardex (as of Sep 24, 2026): return on equity 15.1%. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is KARN from its 52-week high?
Kardex trades at CHF 240.50, about 24% below its 52-week high of CHF 315.81 and 12% above the low of CHF 215.50 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of CHF 107.07 is for.
Which stocks are comparable to Kardex?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kardex stock attractive at the current price?
The data as of Sep 24, 2026: price CHF 240.50, calculated fair value CHF 107.07 (−55%), Quality Score 65/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KARN calculated?
We run Kardex through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of CHF 107.07, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Kardex itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kardex (KARN)?
The closing price on Sep 23, 2026 was CHF 240.50. Our model-based fair value is CHF 107.07, about −55% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kardex right now?
The price sits above even our optimistic bull case (CHF 133.84). The favourable scenario is already priced in. Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Kardex (KARN) come from?
Earnings per share at Kardex grew +9.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.9 %, EBIT margin +1.3 %, tax rate −0.8 %, residual (interest, one-offs) −0.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Kardex

How large is the market capitalisation of Kardex (KARN)?
The market capitalisation of Kardex is CHF 1.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kardex (KARN)?
The price-to-sales ratio of Kardex is 2.37 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kardex (KARN)?
Earnings per share at Kardex are CHF 4.97 (price ÷ EPS = P/E 48.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kardex (KARN)?
The dividend yield of Kardex is 2.7% (payout 130%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kardex (KARN)?
The net margin of Kardex is 4.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kardex (KARN)?
The return on equity (ROE) of Kardex is 15.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kardex (KARN)?
On an EBIT basis the return on assets of Kardex is 18.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kardex (KARN)?
The operating margin of Kardex is 12.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kardex (KARN)?
Revenue at Kardex is growing +3.1% versus a year earlier (3y avg +14.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kardex (KARN)?
Earnings per share at Kardex are growing −87.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Kardex (KARN) hold?
Kardex holds more cash than debt, €96.7M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Kardex in the live analysis

One click puts Kardex on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.